Fundz Deep Dive
Everything you need to win BioVaxys Technology Corp. — in one platform.
Who to reach, what to say, and why now on BioVaxys Technology Corp. — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on BioVaxys Technology Corp. — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
BioVaxys and Horizon Technology Finance Corp Amend Asset Purchase Agreement to Adjust Performance Milestone
Sep 29, 2025•9 months ago
Contract Type
agreement
EtobicokeBiotechnologyHealth CareTherapeuticsDescription
BioVaxys Technology Corp. and Horizon Technology Finance Corporation have executed an amendment to their Asset Purchase Agreement, adjusting the performance milestone amount to $1,785,625 to be raised by September 30, 2026. This amendment reflects strategic adjustments to financing goals following earlier revisions.
Related People
Suggested for you
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months